Intended Use

LGI-Flag™ is a computational software tool that is intended to identify individuals at risk for lower GI disorders that warrant further evaluation. It is based on complete blood count (CBC) patterns mainly related to erythrocyte features, measured and derived from peripheral venous blood specimens. LGI-Flag™ is indicated for use in individuals of the general population, between 50 and 75 years of age, who are not under active GI surveillance.

LGI-Flag™ 3.0 is recommended for use by healthcare systems and their affiliates (such as care providers and population health managers) within their Information Technology (IT) systems. LGI-Flag™ is an adjunct to established clinical guidelines and a referral for further evaluation should be based on the clinical judgment of the care provider.

Myia is a data driven operating system for virtual care. Myia equips Patients and Clinicians with the tools needed for the patients transition from hospital at home, to 30 day readmit avoidance, to traditional RPM. The shift to value-based reimbursement models necessitates more preventative models of care, Myia's platform crosses these models and facilitates cost savings. Myia is partnering with the leading healthcare organizations around the country. Partners like Mercy Virtual, one of the country's leaders in continuous and preventative chronic care management, including patients with Heart Failure, COPD, Diabetes, and Hypertension. Myia improves quality of life for patients and predicts and prevents costly medical events for care providers. Myia takes a device agnostic approach to daily patient monitoring, applies proprietary machine learning for smart triage, and has a clinician centric application to surface the right patient at the right time into workflow. Partnerships with BioIntellisense and Dispatch health bring a complete Hospital at Home offering to the market.

There are no homegrown options that do all that Myia is capable of from a Clinical Perspective. Myia can be used to monitor patient data in four major settings, Inpatient, Hospital at Home, 30 Day readmit avoidance programs, long term RPM programs.

Myia is the only RPM vendor that we are aware of with Data Scientist on staff as well as Data Analyst who work to stratify data and work with Clients to maximize the value of the Myia platform. By looking across patients clinical indication Myia can predict who should be on the program as well as whom is likely to require a hospital visit. These analytics help reduce costs and patient outcomes.